2.03

1.93% -0.04

Clearmind Medicine Inc (CMND)

Overview News Price History Why CMND Down? Discussions Forecast Stock Split

Clearmind Medicine Inc stock is traded at $2.03, with a volume of 95,877. It is down -1.93% in the last 24 hours and down -36.56% over the past month. Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Previous Close:

$2.07

Open:

$2.07

24h Volume:

95,877

Relative Volume:

0.04

Market Cap:

$3.02M

Revenue:

Net Income/Loss:

$-6.64M

P/E Ratio:

-0.0113

EPS:

-179.3009

Net Cash Flow:

$-5.60M

1W Performance:

-13.98%

1M Performance:

-36.56%

6M Performance:

-91.36%

1Y Performance:

-99.48%

1-Day Range:

$2.03

$2.15

1-Week Range:

$2.00

$2.35

52-Week Range:

$2.00

$524.00

Clearmind Medicine Inc Stock (CMND) Company Profile

Name

Clearmind Medicine Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-06-11

Latest SEC Filings

CMND's Discussions on Twitter

Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CMND Clearmind Medicine Inc	2.03	3.02M	0	-6.64M	-5.60M	-179.30
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Clearmind Medicine Inc Stock (CMND) Latest News

Jul 10, 2026

Clearmind Medicine Submits Formal Response To HHS RFI Highlighting MEAI-Based Candidate CMND-100 For Alcohol Use Disorder And Binge Behaviors - marketscreener.com

Jul 10, 2026

Clearmind submits addiction treatment proposal to U.S. HHS - Investing.com India

Jul 10, 2026

Clearmind submits MEAI addiction treatment prop... - Pluang

Jul 10, 2026

Clearmind Medicine Submits Response to HHS RFI Highlighting MEAI-Based CMND-100 for Alcohol Use Disorder - Quiver Quantitative

Jul 10, 2026

Jul 07, 2026

Clearmind Medicine (CMND) reports successful intranasal MEAI feasibility study - Stock Titan

Jul 07, 2026

Clearmind Medicine : Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration for MEAI - marketscreener.com

Jul 07, 2026

CMND Stock Slides As Traders Gauge Cash Runway And Volatility - StocksToTrade

Jul 07, 2026

Clearmind Medicine Reports Successful Formulation Feasibility for Intranasal MEAI Development Program for Alcohol Use Disorder - Quiver Quantitative

Jul 07, 2026

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI - Yahoo Finance UK

Jul 07, 2026

Clearmind Medicine Company Profile & Introduction - Moomoo

Jul 07, 2026

Jul 02, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 02, 2026

Jun 29, 2026

Clearmind Medicine receives U.S. patent for binge behavior treatment - Investing.com UK

Jun 29, 2026

Clearmind Medicine receives U.S. patent for binge behavior treatment By Investing.com - Investing.com Australia

Jun 29, 2026

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength - The Manila Times

Jun 29, 2026

Jun 27, 2026

Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo

Jun 27, 2026

Jun 26, 2026

Price to earnings forward of Clearmind Medicine Inc. – MUN:CWY0 - TradingView

Jun 26, 2026

Jun 25, 2026

Price to earnings forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 25, 2026

Jun 24, 2026

Price to sales forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 24, 2026

Price to book forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 24, 2026

Jun 23, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part a Treatment in FDA-Regulated Phase I/II Trial - marketscreener.com

Jun 23, 2026